Skip to Main Content

Paper Details

Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort.
Journal of Clinical Endocrinology and Metabolism
6
2021
DM, Diabetes Mellitus, HDL, HOMA-, MetS, Metabolic Syndrome, NMN, Neuromedin N, Pro-NT, Pro-Neurotensin, Stroke, cardiovascular disease, diabetes mellitus, dysglycemia, glucose, high-density lipoprotein, insulin, insulin resistance, metabolic syndrome, neuromedin N, neurotensin, participants, precursor, pro-NT, pro-neurotensin
Author NameAffiliation
April P CarsonUniversity of Alabama at Birmingham
  • 1 - 1

Datasets

Release 1.2